Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database
Journal of Pharmacoepidemiology and Risk Management · 31.03.2026 · 18 (1) · 96-107
DOI: 10.56142/perm.26.0007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, erschienen am 31.03.2026. Verfasst von Gyubi Lee und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lee, G., Lee, S. H., Shin, J., & Lee, H. (2026). Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database. Journal of Pharmacoepidemiology and Risk Management, 18(1), 96-107. https://doi.org/10.56142/perm.26.0007
Vancouver
Lee G, Lee SH, Shin J, Lee H. Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database. Journal of Pharmacoepidemiology and Risk Management. 2026;18(1):96-107. doi:10.56142/perm.26.0007
BibTeX
@article{Lee2026,
author = {Lee, Gyubi and Lee, Seung Hyeon and Shin, Ju-Young and Lee, Hyesung},
title = {Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2026},
volume = {18},
number = {1},
pages = {96--107},
doi = {10.56142/perm.26.0007}
}
EUVIMED